| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Common Stock | Options Exercise | $626K | +9.23K | +35.05% | $67.85 | 35.5K | Nov 12, 2021 | Direct | |
| transaction | IDXX | Common Stock | Sale | -$4.31M | -6.95K | -19.56% | $620.55 | 28.6K | Nov 12, 2021 | Direct | F1 |
| transaction | IDXX | Common Stock | Sale | -$1.41M | -2.27K | -7.95% | $621.26 | 26.3K | Nov 12, 2021 | Direct | F2 |
| holding | IDXX | Common Stock | 18.1K | Nov 12, 2021 | by Estony McKeon Family, LLC |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -9.23K | -100% | 0 | Nov 12, 2021 | Common Stock | 9.23K | $67.85 | Direct | F3, F4 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $620.00 to $621.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $621.045 to $621.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Grant of option to buy 45,535 shares of IDEXX Laboratories, Inc. common stock that vested in five annual installments beginning February 14, 2017. |
| F4 | Not applicable. |